According to the Summary of Product Characteristics (SmPC), these include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea (very common) Decreased appetite (very common) Vomiting (common, affecting up to 1 in 10 people) Constipation (common) Abdominal pain (common) Dyspepsia (common) Cholelithiasis (common) Headache (common) These gastrointestinal effects typically occur during the initial weeks of treatment or following dose escalation, and often diminish over time as the body adjusts to the medication
We believe that the increase in glucose metabolism occurs via up-regulation of glycolytic enzymes, since the observed metabolic effects were accompanied by significant upregulation in mRNA and protein expression of critical glycolytic genes (Fig
Curtis, W
Black pepper increases turmeric absorption by 2,000%
At GobyMeds, we emphasize personalized support and proactive care rather than a one-size-fits-all experience
Beyond glycemic control and weight reduction, GLP-1RAs confer cardiovascular, renal, and metabolic benefits, positioning them among the most promising therapeutic options, particularly in obese patients with diabetes (111)
